06.11.2024 • News

Solenis Completes Acquisition of BASF’s Mining Flocculants Business

US specialty chemicals company Solenis has acquired BASF’s flocculants business for mining applications. With this strategic acquisition, Solenis enhances its portfolio for mining and mineral processing customers. The transaction, for which financial details were not disclosed, was first announced in July.

The new product portfolio includes flocculants and other products used for solid-liquid separation and material handling in mining applications.

This acquisition, Solins commented, underscores the company’s commitment to providing innovative and sustainable solutions that improve operational efficiency and environmental performance.

“We are excited to welcome BASF’s flocculants business into the Solenis family,” said John Panichella, CEO of Solenis. “This acquisition aligns with our strategic vision to be the leading provider of specialty chemicals for the mining industry. By combining our expertise and resources, we can deliver even greater value to our customers.”

The acquisition includes BASF’s customers, intellectual property and a team of experts. Solenis said that it will ensure a seamless transition for BASF’s customers.

© Solenis
© Solenis

Company

Solenis LLC

2475 Pinnacle Drive
19803 Wilmington
US

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.